Correlation Between AptaBio Therapeutics and Vieworks
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Vieworks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Vieworks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Vieworks Co, you can compare the effects of market volatilities on AptaBio Therapeutics and Vieworks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Vieworks. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Vieworks.
Diversification Opportunities for AptaBio Therapeutics and Vieworks
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between AptaBio and Vieworks is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Vieworks Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vieworks and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Vieworks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vieworks has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Vieworks go up and down completely randomly.
Pair Corralation between AptaBio Therapeutics and Vieworks
Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 2.48 times more return on investment than Vieworks. However, AptaBio Therapeutics is 2.48 times more volatile than Vieworks Co. It trades about -0.01 of its potential returns per unit of risk. Vieworks Co is currently generating about -0.03 per unit of risk. If you would invest 1,220,000 in AptaBio Therapeutics on September 2, 2024 and sell it today you would lose (568,000) from holding AptaBio Therapeutics or give up 46.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AptaBio Therapeutics vs. Vieworks Co
Performance |
| Timeline |
| AptaBio Therapeutics |
| Vieworks |
AptaBio Therapeutics and Vieworks Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AptaBio Therapeutics and Vieworks
The main advantage of trading using opposite AptaBio Therapeutics and Vieworks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Vieworks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vieworks will offset losses from the drop in Vieworks' long position.| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |